Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuropediatrics"
DOI: 10.1055/s-0039-1695786
Abstract: A 6.5-year-old female patient with a TSC2 mutation had been given everolimus (EVE) for 3 years for pharmacoresistant focal epilepsy and for life-threatening, severe ventricular dysrhythmia. EVE had been started with daily dose of 0.15 mg/kg/day and…
read more here.
Keywords:
trough levels;
cannabidiol interacts;
cbd;
blood trough ... See more keywords